JIM
ANIK icon

Jupiter Investment Management’s Anika Therapeutics ANIK Stock Holding History

Jupiter Investment Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-18,841
Closed -$901K – 364
2016
Q3 		$901K Buy
+18,841
New +$931K 0.02% 240

Other funds holding ANIK

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Jupiter Investment Management's ANIK Position: Q4 2016 in Review

Jupiter Investment Management sold out of Anika Therapeutics (ANIK) in Q4 2016, closing a stake of 18,841 shares — an estimated $901K sold.

Jupiter Investment Management first reported a position in ANIK in Q3 2016 and held it in 1 quarter. The position peaked at $901K in Q3 2016. 158 funds tracked by Wall St. Rank hold ANIK as of Q4 2016.

  • Jupiter Investment Management reported no remaining Anika Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Jupiter Investment Management sold 18,841 Anika Therapeutics shares in Q4 2016, an estimated $901K.
  • Jupiter Investment Management first reported a position in Anika Therapeutics in Q3 2016 and held it in 1 quarter.
  • Jupiter Investment Management's Anika Therapeutics position peaked at $901K in Q3 2016.
  • 158 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2016.

Based on Jupiter Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.